Healthcare -
Biotechnology - NASDAQ - US
$ 1.93
-2.53 %
$ 69.7 M
Market Cap
-0.44
P/E
INO - COST OF REVENUE
Cost of Revenue INO - Inovio Pharmaceuticals, Inc.
3.5 M
LAST VALUE
-13.94%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR